Medical Equipment

Internal Neuromodulation Devices Industry Insights 2025 – Market Forecast for Executives and Planners

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Internal Neuromodulation Devices Market Size Changed, over the years?

The market size for internal neuromodulation devices has seen significant growth in recent times. The market is projected to expand from $2.59 billion in 2024 to $2.77 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. Factors contributing to the growth over the historic period include management of chronic pain, the increasing aging population, clinical research and trials, the prevalence of neurological disorders, and heightened awareness and acceptance among patients.

How Much Will the Internal Neuromodulation Devices Market Be Worth in 2029?

In the coming years, the market size for internal neuromodulation devices is predicted to experience significant expansion. It is projected to escalate to “$3.94 billion by 2029 with a compound annual growth rate (CAGR) of 9.2%. The anticipated growth during the forecast period is driven by factors such as the emergence of personalized medicine, increased healthcare spending, strategic alliances and partnerships, evidence of improved patient outcomes, and alterations to the regulatory landscape. Key trends foreseen for the forecast period comprise the development of miniaturization and implantable technologies, advancements in wireless connectivity and remote surveillance, the broadening scope of neuromodulation applications, precision modulation through closed-loop systems, and a heightened emphasis on patient-centric design.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10222&type=smp

Which is the Largest Company in the Internal Neuromodulation Devices Market?

Major companies operating in the internal neuromodulation devices market include Medtronic plc, Boston Scientific Corporation, BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, EnteroMedics Inc., LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

What Are the Main Market Drivers in the Internal Neuromodulation Devices Industry?

The growth of the internal neuromodulation devices market is projected to rise due to the escalating frequency of neurologic diseases. These diseases, which affect the nervous system, including the brain, spinal cord, and nerves, fall under a wide range of disorders. Internal neuromodulation devices are medical tools employed for the treatment of neurological and psychiatric disorders by sending electrical stimulation to certain areas of the nervous system. These devices can alleviate symptoms such as chronic pain, movement disorders, and mood disorders, and can enhance a patient’s quality of life by alleviating symptoms and facilitating day-to-day activities. For instance, the National Library of Medicine in the US disclosed in April 2023 that 6.7 million Americans were dealing with Alzheimer’s in 2023; this figure is predicted to soar to 13.8 million by 2060. Similarly, a report by the House of Lords Library in the UK in May 2022 revealed that as of January 31, 2022, the neurology workforce in England had grown to 1,638 full-time equivalent staff, up from 1,562 in 2021 and 1,468 in 2020. Consequently, the rising frequency of neurologic diseases is stimulating the expansion of the internal neuromodulation devices market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10222&type=smp

How Is the Internal Neuromodulation Devices Market Segments Structured?

The internal neuromodulation devices market covered in this report is segmented –

1) By Type: Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator

2) By Technology Type: Internal Neuromodulation, External Neuromodulation

3) By Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials

4) By Application: Failed Back Surgery Syndrome, Parkinson’s Disease, Urinary Incontinence, Epilepsy, Gastroparesis

5) By End-User: Hospitals, Clinics, Home Healthcare, Community Healthcare

Subsegments:

1) By Spinal Cord Stimulator: Traditional Spinal Cord Stimulator, Rechargeable Spinal Cord Stimulator, Non-Rechargeable Spinal Cord Stimulator

2) By Deep Brain Stimulator: Single Lead Deep Brain Stimulator, Dual Lead Deep Brain Stimulator, Adaptive Deep Brain Stimulator

3) By Sacral Nerve Stimulator: Implantable Sacral Nerve Stimulator, External Sacral Nerve Stimulator

4) By Vagus Nerve Stimulator: Implantable Vagus Nerve Stimulator, Transcutaneous Vagus Nerve Stimulator

5) By Gastric Neuro Stimulator: Implantable Gastric Neuro Stimulator, External Gastric Neuro Stimulator

What Strategic Trends Are Transforming the Internal Neuromodulation Devices Market?

The advancement of product technology is a prominent trend showcasing in the internal neuromodulation devices marketplace. Key players in this sector are increasingly emphasizing on the development of innovative technologies to maintain their market standing. To illustrate, in March 2023, Neuromod Device Ltd., a medical equipment company based in Ireland, made known that its Lenire system received De Novo clearance from the US Food and Drug Administration (FDA). The Lenire system, which employs a blend of auditory and tongue stimulation, is designed to treat tinnitus, a neurological condition marked by a ringing sensation in the ears. It leverages a two-fold approach for neurostimulation – Bluetooth headphones relay unique auditory stimuli to stimulate the auditory nerve while Neuromod’s Tonguetip gadget, set in the mouth, delivers mild electric simulation to the surface of the tongue. With this innovative Lenire technology at their disposal, otolaryngologists can now suggest it for patients who are experiencing at least a moderate disruption in their daily lives due to tinnitus.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/internal-neuromodulation-devices-global-market-report

Which Global Regions Offer the Highest Growth in the Internal Neuromodulation Devices Market?

North America was the largest region in the internal neuromodulation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10222

This Report Delivers Insight On:

1. How big is the internal neuromodulation devices market, and how is it changing globally?

2. Who are the major companies in the internal neuromodulation devices market, and how are they performing?

3. What are the key opportunities and risks in the internal neuromodulation devices market right now?

4. Which products or customer segments are growing the most in the internal neuromodulation devices market?

5. What factors are helping or slowing down the growth of the internal neuromodulation devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model